Latest News and Press Releases
Want to stay updated on the latest news?
-
Tronox stock fell 38% after lowering its 2025 outlook and dividend. The complaint alleges defendants overstated demand and growth while downplaying risks.
-
Savara stock declined 31.7% after the FDA declined to file its MOLBREEVI application, citing incomplete chemistry, manufacturing, and controls information.
-
Robbins LLP is Investigating Allegations that MoonLake Immunotherapeutics (MLTX) Mislead Investors Regarding the Efficacy of its Drug Candidate
-
Name Change Completed
-
Name Change Completed
-
Robbins LLP is Investigating Allegations that Dow Inc. (DOW) Failed to Disclose the Truth about its Business Prospects
-
Robbins LLP is Investigating Allegations that Quantum Corporation (QMCO) Had Deficiencies in its Internal Control Over Financial Reporting
-
Robbins LLP is Investigating Allegations that SelectQuote, Inc. (SLQT) Violated the False Claims Act
-
Robbins LLP is Investigating Allegations that Sarepta Therapeutics, Inc. (SRPT) Mislead Investors Regarding the Safety its ELEVIDYS Drug
-
Bullet Blockchain changes its name